Edward T Mathers's Net Worth

$130 Million

Estimate Recalculated Jul 12, 2024 03:32PM EST

Who is Edward T Mathers?

Edward T Mathers has an estimated net worth of $130 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Savara Inc, Trevi Therapeutics, Inc., SYNLOGIC, INC., Akouos, Inc., Ra Pharmaceuticals, Inc., Senti Biosciences, Inc., ObsEva SA, Liquidia Technologies Inc, MEDIMMUNE INC /DE, and Korro Bio, Inc..

SEC CIK

Edward T Mathers's CIK is 0001328625

Past Insider Trading and Trends

2021 was Edward T Mathers's most active year for acquiring shares with 12 total transactions. Edward T Mathers's most active month to acquire stocks was the month of May. 2007 was Edward T Mathers's most active year for disposing of shares, totalling 7 transactions. Edward T Mathers's most active month to dispose stocks was the month of May. 2022 saw Edward T Mathers paying a total of $145,200,001.20 for 4,338,515 shares, this is the most they've acquired in one year. In 2006 Edward T Mathers cashed out on 80,000 shares for a total of $1,303,420.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3K
3K
Jun 21
Form 4
0
0
Jun 18
Form 4
0
0
Jun 21
Form 4
5.77K
5.77K
Mar 2
Form 4
0
0
Jun 8
Form 4/A
0
0
Jun 9
Form 4
0
0
Jun 9
Form 4
0
0
Jun 17
Form 4
0
0
Jun 19
Form 4
0
0
Jun 6
Form 3
0
0
No matching records found

NeueHealth, Inc. (BHG) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 8
Form 4
0
0
Dec 19
Form 4
0
0
Oct 31
Form 4
0
0
Sep 15
Form 4
0
0
Aug 11
Form 4
0
0
Oct 17
Form 3
0
0
Form 3
0
0
No matching records found

Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
7.69M
$19.00
7.69M
Jun 28
Form 3
0
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 2
Form 4
0
0
Jun 4
Form 4
0
0
Jun 11
Form 3
0
0
No matching records found

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 6
Form 4
0
0
Jun 1
Form 4
0
0
Apr 8
Form 3
0
0
No matching records found